Effects of rifaximin on indomethacin-induced intestinal damage in guinea-pigs

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 3, 2014, Pages 344-351

  Ciobanu, L ^a   Taulescu, M ^b   Prundus, R ^a   Diaconu, B ^a   Andreica, V ^a   Catoi, C ^b   Pascu, O ^a   Tantau, M ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

Author keywords

Gut immunology; Indomethacin; Rifaximin

Indexed keywords

INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; RIFAXIMIN; GASTROINTESTINAL AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMYCIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; ENDOTHELIUM LESION; EOSINOPHIL; FEMALE; GUINEA PIG; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; MALE; MICROSCOPY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; QUANTITATIVE ANALYSIS; RANK SUM TEST; SMALL INTESTINE; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; ENTERITIS; ENZYMOLOGY; INTESTINE MUCOSA; MICROBIOLOGY; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ENTERITIS; FEMALE; GASTROINTESTINAL AGENTS; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; INTESTINAL MUCOSA; NEUTROPHIL INFILTRATION; NITRIC OXIDE SYNTHASE TYPE II; RIFAMYCINS;

EID: 84896998411     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. MCCRACKEN VJ, LORENZ RG. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001; 3: 1-11.
2. NAGLER-ANDERSON C. Tolerance and immunity in the intestinal immune system. Crit Rev Immunol 2000; 20: 103-120.
3. ARTIS D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420.
4. NEWBERRY RD, MCDONOUGH JS, STENSON WF, LORENZ RG. Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response. J Immunol 2001; 166: 4465-4472.
5. CEREZO CS, KULPA-OLIVER V, GRUPPUSO PA, MORIN MJ. Regulation of adolescent rat intestinal epithelial inducible nitric oxide synthase expression in endotoxin tolerance: modulation of signal transduction. Shock 2004; 21: 476-483.
6. TAKEUCHI K, YOKOTA A, TANAKA A, TAKAHIRA Y. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs. Dig Dis Sci 2006; 51: 1250-1259
7. KONAKA A, KATO S, TANAKA A, KUNIKATA T, KOROLKIEWICZ R, TAKEUCHI K. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacininduced small intestinal lesions in rats. Pharmacol Res 1999; 40: 517-524.
8. WEISSENBORN U, MAEDGE S, BUETTNER D, SEWING KF. Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology 1985; 30: 32-39.
9. WHITTLE BJ. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 2003; 17: 301-313.
10. KONAKA A, NISHIJIMA M, TANAKA A, KUNIKATA T, KATO S, TAKEUCHI K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 1999; 50: 25-38.
11. TANAKA A, KUNIKATA T, MIZOGUCHI H, KATO S, TAKEUCHI K. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. J Physiol Pharmacol 1999; 50: 405-417.
12. EVANS SM, WHITTLE BJ. Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat. Eur J Pharmacol 2003; 461: 63-71.
13. NANDI J, SAUD B, ZINKIEVICH JM, PALMA DT, LEVINE RA. 5-aminosalicylic acid improves indomethacin-induced enteropathy by inhibiting iNOS transcription in rats. Dig Dis Sci 2008; 53: 123-132.
14. LANAS A, SCARPIGNATO C. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics? Digestion 2006; 73(Suppl 1): 136-150.
15. KAMIL R, GEIER MS, BUTLER RN, HOWARTH GS. Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy. Dig Dis Sci 2007; 2: 1247-1252.
16. HOOVER WW, GERLACH EH, HOBAN DJ, ELIOPOULOS GM, PFALLER MA, JONES RN. Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative. Diagn Microbiol Infect Dis 1993; 16: 111-118.
17. GRAHAMDY, OPEKUN AR, WILLINGHAM FF, QURESHIWA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005; 3: 55-59.
18. ANTHONY A, DHILLON AP, NYGARD G, HUDSON M, PIASECKI C, STRONG P, TREVETHICK MA, CLAYTON NM, JORDAN CC, POUNDER RE. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther 1993; 7: 29-39.
19. KRUIDENIER L, KUIPER I, LAMERS CB, VERSPAGET HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003; 201: 28-36.
20. MACLAURIN BP, WATTS C, PALMER DG. Protection by sucralfate against indomethacin induced gastric ulceration in the guinea pig. Pathology 1985; 17: 408-411.
21. TOMISATO W, TSUTSUMI S, ROKUTAN K, TSUCHIYA T, MIZUSHIMA T. NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1092-G1100.
22. TANAKA K, TOMISATO W, TSUTSUMI S, HOSHINO T, TSUCHIYA T, MIZUSHIMA T. Cytotoxic synergy between indomethacin and hydrochloric acid in gastric mucosal cells. Biol Pharm Bull 2004; 27: 1188-1192.
23. ETTARH RR, CARR KE. Morphometric analysis of the small intestinal epithelium in the indomethacintreated mouse. J Anat 1996; 189: 51-56.
24. FIORUCCI S, DISTRUTTI E, MENCARELLI A, BARBANTI M, PALAZZINI E, MORELLI A. Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. Digestion 2002; 66: 246-256.
25. BJARNASON I, HAYLLAR J, SMETHURST P, PRICE A, GUMPEL MJ. Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut 1992; 33: 1204-1208.
26. LEITE AZ, SIPAHI AM, DAMIÃO AO, COELHO AM, GARCEZ AT, MACHADO MC, BUCHPIGUEL CA, LOPASSO FP, LORDELLO ML, AGOSTINHO CL, LAUDANNA AA. Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 2001; 48: 163-167.
27. WATANABE T, HIGUCHI K, KOBATA A, NISHIO H, TANIGAWA T, SHIBA M, TOMINAGA K, FUJIWARA Y, OSHITANI N, ASAHARA T, NOMOTO K, TAKEUCHI K, ARAKAWA T. Nonsteroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57: 181-187.
28. KOO HL, DUPONT HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010; 26: 17-25
29. BESEGHI U, DE'ANGELIS GL. Comparison of two nonabsorbable antibiotics for treatment of bacterial enteritis in children. Eur Rev Med Pharmacol Sci. 1998; 2: 131-136.
30. LAURITANO EC, GABRIELLI M, SCARPELLINI E, OJETTI V, ROCCARINA D, VILLITA A, FIORE E, FLORE R, SANTOLIQUIDO A, TONDI P, GASBARRINI G, GHIRLANDA G, GASBARRINI A. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci. 2009; 13: 111-116.
31. SCARPELLINI E, GIORGIO V, GABRIELLI M, FILONI S, VITALE G, TORTORA A, OJETTI V, GIGANTE G, FUNDARÒ C, GASBARRINI A. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2013; 17: 1314-1320.
32. WATANABE T, NISHIO H, TANIGAWA T, YAMAGAMI H, OKAZAKI H, WATANABE K, TOMINAGA K, FUJIWARA Y, OSHITANI N, ASAHARA T, NOMOTO K, HIGUCHI K, TAKEUCHI K,ARAKAWA T. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol 2009; 297: G506-G513.
33. AKIBA Y, GUTH PH, ENGEL E, NASTASKIN I, KAUNITZ JD. Dynamic regulation of mucus gel thickness in rat duodenum. Am J Physiol Gastrointest Liver Physiol 2000; 279: G437-G447.